ArticleNature communications2017

Muscle-specific CRISPR/Cas9 dystrophin gene editing ameliorates pathophysiology in a mouse model for Duchenne muscular dystrophy.

Niclas E Bengtsson et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.